Tumor interstitial fluid and postoperative recurrence of tumors: An experimental study for verifying hypothesis of "tumor-phlegm microenvironment"

Chinese Journal of Integrative Medicine

Volumn 16, Issue 5, 2010, Pages 435-441

  Sun, Da Zhi ^a   Ju, Da Wei ^a   He, Jin ^a   Lu, Ye ^a   Wu, Feng ^a   Li, Chang ^a   Wei, Pin Kang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Interleukin 8; Muddy phlegm; Tumor interstitial fluid; Tumor recurrence

Indexed keywords

INTERLEUKIN 8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CONTROLLED STUDY; INTERSTITIAL FLUID; MOUSE; MUSCLE TISSUE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TUMOR; TUMOR CELL; TUMOR INTERSTITIAL FLUID; TUMOR RECURRENCE; ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL NEOPLASM; EXTRACELLULAR FLUID; PATHOLOGY; POSTOPERATIVE PERIOD; RECURRENT DISEASE;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR FLUID; INTERLEUKIN-8; MICE; NEOPLASMS, EXPERIMENTAL; POSTOPERATIVE PERIOD; RECURRENCE;

EID: 79952197336     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-010-0537-6     Document Type: Article

References (24)

1. Bohner H, Zimmer T, Hopfenmuller W, Berger G, Buhr HJ. Detection and prognosis of recurrent gastric canceris routine follow-up after gastrectomy worthwhile? Hepatogastroenterology 2000;47:1489-1494.
2. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003;362:305-315. (Pubitemid 36936845)
3. Wei P, Xu L, Sun D, Shi J, Qin Z, Lu Y. Relations between phlegm and generation and development of gastric cancer. J Tradit Chin Med (Chin) 2008;28:152-155.
4. Wei PK, Yu ZH, Xu L, Qin ZF, Shi J, Sun DZ. Correlation between phlegm theory of traditional Chinese medicine and tumor stroma in gastric cancer. Chin J Basic Med Tradit Chin Med (Chin) 2006;2:309-312.
5. Fujimoto J. Second primary malignancy after surgical adjuvant therapy for gastric cancer. Gan To Kagaku Ryoho 1999;26:2000-2014.
6. Tsukuma H, Tanaka H, Koyama Y, Kinoshita N, Koyama H, Furukawa H. Descriptive and analytical epidemiology of second primaries in Osaka, Japan. Gan To Kagaku Ryoho 1999;26:1980-1987.
7. Hu J, Chen Z, Zhang B. System evaluation of postoperative chemotherapy of gastric tumor. Chin J Evid-Based Med (Chin) 2003; 3:4-9.
8. Silltti SW, Paku S. Autocrine motility factor and extracellular matrix-II degradation or remodeling of ubstratum componenets directs the motile response of tumor cells. Int J Cancer 1998;76:129-134.
9. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 2001;12:375-391. (Pubitemid 32851749)
10. Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev 2002;13:143-154. (Pubitemid 34229389)
11. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995;270:27348-27357.
12. Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, Allegretti M. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol Ther 2006;112:139-149. (Pubitemid 44314001)
13. Moore BB, Arenberg DA, Addison CL, Keane MP, Strieter RM. Tumor angiogenesis is regulated by CXC chemokines. J Lab Clin Med1998;132:97-103.
14. Strieter RM, Belperio JA, Phillips RJ, Keane MP. CXC chemokines in angiogenesis of cancer. Semin Cancer Biol 2004;14:195-200. (Pubitemid 38586745)
15. Kitadai Y, Takahashi Y, Haruma K, Naka K, Sumii K, Yokozaki H, et al. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer 1999;81:647-653. (Pubitemid 29458860)
16. Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, et al. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 1998;152:93-100. (Pubitemid 28028050)
17. Kitadai Y, Haruma K, Mukaida N, Ohmoto Y, Matsutani N, Yasui W, et al. Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Cancer Res 2000;6:2735-2740. (Pubitemid 30482112)
18. Miyamoto M, Shimizu Y, Okada K, Kashii Y, Higuchi K, Watanabe A. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells. Cancer Immunol Immunother 1998;47:47-57. (Pubitemid 28430530)
19. Ueda T, Shimada E, Urakawa T. Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 1994;29:423-429 (Pubitemid 24262709)
20. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-4 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003;170:3369-3376. (Pubitemid 36302216)
21. Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, Yang XD, et al. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin Cancer Res 2003;9:3167-3175. (Pubitemid 36993279)
22. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, et al. Inhibition of IL-8 attennuate angiogenesis in bronchogenic carcinoma. J Exp Med 1994;179:1409-1415. (Pubitemid 24129558)
23. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM. lnhibition of reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996;97:2792-2802. (Pubitemid 26197092)
24. Miyamoto M, Shimizu Y, Okada K, Kashii Y, Higuchi K, Watanabe A. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells. Cancer Immunol Immunother 1998;47:47-57. (Pubitemid 28430530)